Magenta Therapeutics' Series C Round

Magenta Therapeutics raised a round of funding on April 09, 2018.

Magenta Therapeutics (NASDAQ: MGTA) is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases. …

Articles about Magenta Therapeutics' Series C Round: